Unaudited Financial Results for the quarter and half year ended 30th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemcrux Enterprises reported standalone revenue from operations of ₹1,855.31 lakhs for Q2 FY26, up from ₹1,775.62 lakhs in Q2 FY25, with H1 FY26 revenue at ₹3,530.04 lakhs versus ₹3,486.47 lakhs in H1 FY25. However, profitability weakened sharply: standalone H1 FY26 profit after tax fell to ₹138.39 lakhs from ₹238.57 lakhs a year ago, a drop of about 42%, while Q2 standalone PAT declined to ₹79.95 lakhs from ₹114.75 lakhs. Consolidated numbers show an even sharper squeeze, with H1 FY26 PAT collapsing to just ₹36.55 lakhs (from ₹238.57 lakhs), as finance costs and depreciation rose significantly. The auditor (Naresh & Co.) issued an unqualified limited-review report, and the company now consolidates subsidiary Kalichem Private Limited as a wholly-owned unit after acquiring the remaining 50% stake on 27 February 2025. Operating cash flow remained healthy at ₹554.49 lakhs standalone (₹806.97 lakhs consolidated).
Despite stable to slightly higher revenue, sharp profit compression driven by higher finance costs and depreciation is a negative signal for shareholders. The dramatic gap between standalone and consolidated PAT suggests margin pressure is concentrated in the newly-fully-owned subsidiary, which warrants close monitoring in coming quarters.